Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals

Nunzia Pharmaceutical Launches its Breakthrough NUNZIA Nutraceutical and Pharma Treatment for Autism Spectrum and Other Anxiety Disorders

SAN CLEMENTE, CA, April 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nunzia Pharmaceutical Corporation (OTC MKTS: NUNZ), an emerging leader in innovative pharmaceutical and nutraceutical based therapies for the treatment of behavioral anxiety symptoms of Autistic Spectrum of Disorders (ASD’s) and other anxiety disorders, is pleased to announce the launch of its landmark NUNZIA nutraceuticals available direct to consumers through the Company’s website, www.nunziapharma.com. NUNZIA provides a highly effective and targeted supplement for a rapidly growing autism market. In 2000, less than 1 in 150 American children were affected by autism, a prevalence that is now 1 in 45- there are 1.4 million children and 700,000 American adults are affected with an estimated economic cost of between $11.5 and $60.9 billion per year. 

Current treatments for ASD’s have had limited efficacy, with broad acting drugs such as antidepressants, antipsychotics, SSRI’s and amphetamines being employed to varying and inconsistent treatment results. In addition to the unmet treatment needs for ASD’s, NUNZIA also broadly treats a wide range of related anxiety disorders- from ADHD which affects 4.8% of US adults and 8.7% of adolescents; to anxiety disorders (generalized, panic, and phobia related) that impact over a third of US adults and adolescents; and depressive disorders affecting up to 7.1% of the US adult population.

NUNZIA is currently available as a nutraceutical supplement, with prescribed and over-the-counter pharmaceutical treatments planned, and is unique within this space as a positive treatment quite unlike other drugs and supplements on the market. With no known negative side effects, no known addictions, and no clinical reaction to alcohol- NUNZIA is one of the safest treatments on the market with no known adverse effects on vital organs. 

NUNZIA nutraceuticals are a combination of 16 vitamins, minerals, and herbs which directly focus and target the hippocampus area of the brain, where all anxiety-based disorders begin- NUNZIA directly targets anxiety in the hippocampus, improving the function, which is a primary cause of the affiliations and compulsory disorders present in ASDs and anxiety disorders. Treatment The NUNZIA supplement with NUNZIA has demonstrated positive results for affected patients, increased memory, improved fine motor skills and increased speech ability while decreasing the anxiety, stress, fixations, and fidgeting that complicate social interactions and life with ASDs and other anxiety disorders.